A new 42-page report published in the International Journal of Cardiovascular Research & Innovation has garnered information and data from 341 peer-reviewed studies that paint an alarming picture of Myocarditis risks post mRNA shots, and also raising questions of why regulators remain silent on the issue.
As Australians were forced to choose between taking an experimental therapeutic or face dismissal and expulsion from the “vaccinated economy”, it now appears that politicians risked the lifelong heart health of every Australian who took an mRNA shot with limited transparency of initial trial data and no long-term safety data.
The report uses various sources of epidemiological data to collectively highlight the risks of myocarditis associated with Covid-19 mRNA vaccines, particularly when administered to younger populations. Spanning a wide range of methodologies and contexts, these sources include the registrational trial data from Pfizer and Moderna, confidential post-EUA safety data, prospective cardiac function studies, autopsy findings, analyses from the U.S. military health system, actuarial data from life insurance companies, large-scale passive surveillance data, individual case reports, and observations from professional athletic organisations.
In a re-analyses of Pfizer and Moderna trial data striking revelations concerning these serious cardiac issues were revealed in the registrational trial data that led to global distribution of the Covid-19 mRNA products.
‘A combined reanalysis of the Pfizer and Moderna pivotal found a 45 per cent trend increase for cardiovascular death (RR, 1.45; 95 per cent CI 0.67-3.13) in the mRNA arms compared to the placebo arms. In the Pfizer trial, there were twice as many cardiovascular AEs in the mRNA arm versus placebo. The rigorous reanalysis of this trial by Fraiman and colleagues demonstrated a statistically significant 36 per cent higher risk (RR, 1.36; 95 per cent CI: 1.02-1.83) of serious AEs in the mRNA group versus placebo.’ Stated the report.
Another in-depth reanalysis, by Michels and colleagues, of data from Pfizer’s six-month interim report, along with additional narrative reports not originally shared with the FDA’s vaccine advisory committee prior to authorisation, found similar risks.
‘Their study showed a significant 3.7-fold increase (OR 3.7; 95 per cent CI 1.02–13.2, p=0.03) in serious cardiac events among the BNT162b2 recipients [104]. Two of the sudden deaths (by cardiac arrest) among women in the trial were concealed by Pfizer until after the emergency use authorizations (EUAs) were issued. Remarkably, neither the original trial publication nor Pfizer’s Summary Clinical Safety report had addressed the trial’s own safety signal regarding serious cardiac events.’ Stated the report.
In the USA the VAERS pharmacovigilance database collects voluntary reports from individuals who have experienced or observed side effects or AEs from vaccines and biological products. Despite Harvard-sponsored research that estimated that, on average, less than one in every 100 AEs (<1 per cent) experienced in the general population is submitted to VAERS, despite this conservative estimate, the reported AEs are alarming.
‘A recent VAERS analysis revealed that myocarditis cases reported in VAERS following the 2021 Covid-19 vaccine rollouts were 223 times higher than the combined average for all vaccines over the previous 30 years. This translates to a dramatic 2500 per cent increase in reported cases compared to the period before 2021. Demographic data from the study showed that youths accounted for 50 per cent of the cases, with males comprising 69 per cent. Notably, 76 per cent of those cases reported to VAERS required emergency medical care or hospitalization, and tragically, 92 individuals died (3 per cent of cases).’ Stated the report.
‘A study by Sharff et al. examined myocarditis rates in a group of 65,785 individuals aged 18 to 39 and reported an incidence of 9.1 cases per 100,000 booster doses within 21 days post-vaccination.’ Stated the report.
Graph 3 shows that the Covid-19 vaccinations were associated with 118 times more reports (Graph 3 – right) and perhaps even more alarming, 6.2 times as many types of AEs (Graph 3 – left)
Graph 4 shows VAERS myocarditis reports as of September 29, 2023 by age and dose number. Notably, there was a five-fold increase in myocarditis reports among 15-year-old males following the second dose (green bars), with a general trend of increased cases after subsequent doses [141]. Across all ages, myocarditis reports were more prevalent following the second mRNA dose, suggesting a potential causal link between myocarditis and Covid-19 vaccinations.
In U.S. military data, approximately 80 per cent of the U.S. military consisted of males, with about 75 per cent being 35 years old or younger. The 2021 Defense Medical Epidemiology Database data allowed the comparison of myocarditis rates from five prepandemic years to 2021. This demonstrated that the incidence of myocarditis was more than double that of each of the preceding five years.
The study authors also delve into great detail on what they perceive to be misconceptions that aim to minimise the documented harm, such as the notion that coronavirus infections cause more myocarditis than Covid-19 vaccinations. Backing these claims is a detailed explanation and peer-reviewed evidence on the mechanism that leads to the potential harm in patients.
Independent Medical Alliance Senior Fellow of Pediatric Cardiology Dr. Kirk Milhoan MD, PhD, FACC, FAAP, said in an interview said the study put a compiled a lot of data.
“It’s a compilation of studies that really have been out there since 2021. We saw a signal in the vaccine product causing problems, especially in the young adults, especially young males, that was causing heart inflammation, and so what we have done is compiled all those different peer reviewed journals, articles and data and put them in one place, easily accessible with 42 pages and 341 references of our concerns that this is a real issue, and these vaccines do little good for healthy children and young adults.” said Dr Milhoan
When asked if they were able to distinguish the cause of myocarditis between a Covid infection versus an adverse reaction to the Covid Dr Milhoan said it was clear.
“Yes, it’s very clear from the number of reasons that we’ve been able to evaluate, and primarily, there was a great study out of the Nordic countries that studied 23 million children and young adults, and they found that the people who had the least amount of myocarditis were the unvaccinated. As you increase the number of vaccine doses, or you use Moderna versus Pfizer, your risk just kept stepping up in terms of your risk for myocarditis, once again, in a disease state that is really very mild for healthy children and young adults.”
“A new study released by Yale said that they’re still seeing free floating spike protein, which is what that vaccine asked the body to make, which is a cardio toxin, still floating around in the body for over 700 days. It was supposed to just be put in and your body has a immune response and then it went away, but it is hanging around in some, so it’s not transitory. It’s not resolving over time.” Said Dr Milhoan
The paper concludes ‘Given the substantial evidence presented here concerning cardiotoxicity and serious cardiac events in younger generations, we strongly recommend the immediate withdrawal of Covid-19 mRNA products from the market.”
You can find the full paper here: https://cardiovascular-research-and-innovation.reseaprojournals.com/Articles/myocarditis-after-sars-cov-2-infection-and-covid-19-vaccination-epidemiology-outcomes-and-new-perspectives.
This article appeared in The Koondrook and Barham Bridge Newspaper, 15 May 2025.
